Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.470EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.31 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.51 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used